These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35954165)
1. Deep Learning-Based Image Analysis for the Quantification of Tumor-Induced Angiogenesis in the 3D In Vivo Tumor Model-Establishment and Addition to Laser Speckle Contrast Imaging (LSCI). Kuri PM; Pion E; Mahl L; Kainz P; Schwarz S; Brochhausen C; Aung T; Haerteis S Cells; 2022 Jul; 11(15):. PubMed ID: 35954165 [TBL] [Abstract][Full Text] [Related]
2. Application of Laser Speckle Contrast Imaging (LSCI) for the Angiogenesis Measurement of Tumors in the Chorioallantoic Membrane (CAM) Model. Pion E; Haerteis S; Aung T Methods Mol Biol; 2023; 2572():141-153. PubMed ID: 36161414 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a chick embryo chorioallantoic membrane (CAM) based platform for evaluation of vasoactive medications. Chen L; Wang S; Feng Y; Yu J; Coudyzer W; Van Ongeval C; Geng L; Li Y; Ni Y Microvasc Res; 2022 Jul; 142():104372. PubMed ID: 35483521 [TBL] [Abstract][Full Text] [Related]
4. Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model. Pion E; Asam C; Feder AL; Felthaus O; Heidekrueger PI; Prantl L; Haerteis S; Aung T Microvasc Res; 2021 Jan; 133():104072. PubMed ID: 32949573 [TBL] [Abstract][Full Text] [Related]
5. A Novel Artificial Intelligence-Based Approach for Quantitative Assessment of Angiogenesis in the Ex Ovo CAM Model. Faihs L; Firouz B; Slezak P; Slezak C; Weißensteiner M; Ebner T; Ghaffari Tabrizi-Wizsy N; Schicho K; Dungel P Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077809 [TBL] [Abstract][Full Text] [Related]
7. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib. Özcetin A; Aigner A; Bakowsky U Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770 [TBL] [Abstract][Full Text] [Related]
8. Chorioallantoic Membrane Assay as Model for Angiogenesis in Tissue Engineering: Focus on Stem Cells. Merckx G; Tay H; Lo Monaco M; van Zandvoort M; De Spiegelaere W; Lambrichts I; Bronckaers A Tissue Eng Part B Rev; 2020 Dec; 26(6):519-539. PubMed ID: 32220219 [TBL] [Abstract][Full Text] [Related]
9. Establishment of an in ovo chick embryo yolk sac membrane (YSM) assay for pilot screening of potential angiogenic and anti-angiogenic agents. As MN; Deshpande R; Kale VP; Bhonde RR; Datar SP Cell Biol Int; 2018 Nov; 42(11):1474-1483. PubMed ID: 30136736 [TBL] [Abstract][Full Text] [Related]
11. The 3D in vivo chorioallantoic membrane model and its role in breast cancer research. Kohl C; Aung T; Haerteis S; Ignatov A; Ortmann O; Papathemelis T J Cancer Res Clin Oncol; 2022 May; 148(5):1033-1043. PubMed ID: 35122110 [TBL] [Abstract][Full Text] [Related]
12. Chorioallantoic Membrane Microtumor Model to Study the Mechanisms of Tumor Angiogenesis, Vascular Permeability, and Tumor Cell Intravasation. Deryugina EI Methods Mol Biol; 2016; 1430():283-98. PubMed ID: 27172961 [TBL] [Abstract][Full Text] [Related]
13. The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma. Li M; Pathak RR; Lopez-Rivera E; Friedman SL; Aguirre-Ghiso JA; Sikora AG J Vis Exp; 2015 Oct; (104):. PubMed ID: 26484588 [TBL] [Abstract][Full Text] [Related]
14. An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane. Nawara HM; Afify SM; Hassan G; Zahra MH; Atallah MN; Seno A; Seno M Cell Biol Int; 2021 Apr; 45(4):749-756. PubMed ID: 33274828 [TBL] [Abstract][Full Text] [Related]
15. A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays. Gnutti A; Signoroni A; Leonardi R; Corsini M; Presta M; Mitola S Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():763-6. PubMed ID: 26736374 [TBL] [Abstract][Full Text] [Related]
16. Exploration of Chick Embryo and Chorioallantoic Membrane on Imaging Navigated Platforms for Anticancer Pharmaceutical Evaluations. Chen L; Yuan M; Zhang X; Li Y; Feng Y; Yu J; Coudyzer W; Xie Y; Xu J; Li Y; Li Y; Ni Y Technol Cancer Res Treat; 2023; 22():15330338231206985. PubMed ID: 37844882 [TBL] [Abstract][Full Text] [Related]
17. 3D monitoring of tumor volume in an in vivo model. Troebs J; Asam C; Pion E; Prantl L; Aung T; Haerteis S Clin Hemorheol Microcirc; 2020; 76(2):123-131. PubMed ID: 32925020 [TBL] [Abstract][Full Text] [Related]
18. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents. Tufan AC; Satiroglu-Tufan NL Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046 [TBL] [Abstract][Full Text] [Related]
19. Chick ex ovo culture and ex ovo CAM assay: how it really works. Dohle DS; Pasa SD; Gustmann S; Laub M; Wissler JH; Jennissen HP; Dünker N J Vis Exp; 2009 Nov; (33):. PubMed ID: 19949373 [TBL] [Abstract][Full Text] [Related]
20. Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules. Deryugina EI; Quigley JP Methods Enzymol; 2008; 444():21-41. PubMed ID: 19007659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]